RSS

SkinVision

An international group of researchers working with Erasmus MC determined that SkinVision – a CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer. Read more

News

An app which allows people to monitor themselves for early signs of skin cancer has been selected to join the NHS Innovation Accelerator. Read more

News